Clinical trial
UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Ages 65 and Under: A Trial Enrolling Subjects to Standard Total Therapy 3 (S-TT3)
NCT00734877 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Ages 65 and Under: A Trial Enrolling Subjects to Standard Total Therapy 3 (S-TT3)
- Lead sponsor
- University of Arkansas
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- July 31, 2008
- Completion date
- September 30, 2028
- Enrollment
- 382 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.